Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer.

Vest MT, Tanoue L, Soulos PR, Kim AW, Detterbeck F, Morgensztern D, Gross CP.

J Thorac Oncol. 2012 Jan;7(1):188-95. doi: 10.1097/JTO.0b013e318236ecbb.

2.

Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.

Lardinois D.

Swiss Med Wkly. 2011 Mar 8;141:w13168. doi: 10.4414/smw.2011.13168. Review.

3.

Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.

Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP.

Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Review.

PMID:
18373987
4.
5.

ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.

De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, Waller DA, Lerut T, Weder W.

Eur J Cardiothorac Surg. 2007 Jul;32(1):1-8. Epub 2007 Apr 19.

PMID:
17448671
7.

Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis.

Lv YL, Yuan DM, Wang K, Miao XH, Qian Q, Wei SZ, Zhu XX, Song Y.

J Thorac Oncol. 2011 Aug;6(8):1350-8. doi: 10.1097/JTO.0b013e31821d4384. Review.

8.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
9.

Radiographic staging of mediastinal lymph nodes in non-small cell lung cancer patients.

Groth SS, Whitson BA, Maddaus MA.

Thorac Surg Clin. 2008 Nov;18(4):349-61. doi: 10.1016/j.thorsurg.2008.07.002. Review.

PMID:
19086605
10.

A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage.

de Cabanyes Candela S, Detterbeck FC.

J Thorac Oncol. 2010 Mar;5(3):389-98. doi: 10.1097/JTO.0b013e3181ce3e5e. Review.

11.

Should all cases of lung cancer be presented at Tumor Board Conferences?

Riquet M, Mordant P, Henni M, Wermert D, Fabre-Guillevin E, Cazes A, Le Pimpec Barthes F.

Thorac Surg Clin. 2013 May;23(2):123-8. doi: 10.1016/j.thorsurg.2013.01.003. Epub 2013 Feb 4. Review.

PMID:
23566964
Items per page

Supplemental Content

Write to the Help Desk